The Use of SPRi for the Characterization of Multiple Ligands: Examples of Alzheimer's Disease Investigation and Circulating Antibodies Bioassay Optimization

This webinar will show the potentialities of the new multiplexing and fully automated SPRi "XelPleX" by illustrating two examples of the simultaneous characterization of multiple biologically relevant interactions.

The first example represents the discovery and the study of the interaction between the endogenous antimicrobial peptide cathelicidin (LL37) and different beta-amyloid aggregation forms spotted onto the SPRi chip surface. This study confirms that cathelicidin is a binding partner of beta-amyloid and suggests its potential role as inhibitor of beta-amyloid fibrils.

The second example concerns the development and the optimization of a peptide microarray for the detection of circulating IgE antibodies in milk allergic patients. SPRi measurements permitted to select the best epitope presentation strategy (i.e. multiple epitope presentation) in order to obtain optimal analytical performances.

Other Webinars from HORIBA

Tell Us What You Think

Do you have a review, update or anything you would like to add to this content?

Leave your feedback
Your comment type

Materials Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.